Metformin for the Treatment of Diabetes in Pregnancy

S

Soroka University Medical Center

Status and phase

Unknown
Phase 3

Conditions

Gestational Diabetes
Diabetes Mellitus Type 2

Treatments

Drug: metformin

Study type

Interventional

Funder types

Other

Identifiers

NCT00414245
sor434306ctil

Details and patient eligibility

About

The purpose of this study is to determine whether metformin is effective and safe in the treatment of diabetes in pregnancy.

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women
  • GDM A2
  • diabetes mellitus type 2
  • singleton pregnancy

Exclusion criteria

  • diabetic nephropathy or proliferative retinopathy
  • cannot swallow tablets

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Central trial contact

Boaz Sheizaf, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems